Dr. Allyson Tracy Tevrizian, MD

Dr. Tevrizian practices at Seneca Surgical in Pleasanton, California.

Dr. Tevrizian's NPI, 1902930753, was assigned on March 15, 2007. Dr. Tevrizian graduated from Duke University School Of Medicine in 1996. Dr. Tevrizian's California license number on file is A064305.

Dr. Tevrizian's primary practice is Seneca Surgical, at 5924 Stoneridge Dr, Pleasanton, CA 94588 in Alameda County. The practice phone is (630) 408-2992.

Dr. Tevrizian's primary practice is Seneca Surgical in Pleasanton, California. Dr. Tevrizian is also affiliated with Stanford Health Care Tri-Valley. The medical group on file is Allergy & Asthma Medical Group of the Bay Area. Dmand AI also links Dr. Tevrizian to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Tevrizian practices, 2 sites in all. Vendor and product names are available with a free account.

Allergy and immunology is Dr. Tevrizian's primary specialty in the NPI Registry, under taxonomy code 207K00000X. Dr. Tevrizian is board certified in allergy & immunology by the American Board of Allergy and Immunology. Dr. Tevrizian has a license on file in California.

Dmand AI lists acute sinusitis, asthma, chronic nasal allergies, chronic sinusitis, hives, immune deficiency disease and upper respiratory infection (URI) among the conditions Dr. Tevrizian treats.

CMS data shows 3,772 Medicare services from Dr. Tevrizian across 12 procedure codes in 2024, for 196 Medicare patients. Medicare paid $61,272 for them. Every service was in an office.

CMS counts 196 Medicare patients who saw Dr. Tevrizian in 2024. The largest group is 65 to 74, with 108 patients. 75% of them have high cholesterol, and 60% have high blood pressure. Their average risk score is 1.00, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Tevrizian's median patient age at 43, with 57% women.

In 2024, Dr. Tevrizian wrote 1,075 Medicare Part D claims for 207 patients. 65% of them were for generic drugs. CMS names the drug for 804 of them, across 20 drugs with 11 or more claims each, at $209,341 in total drug cost. In 2023, CMS named 822 claims across 25 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 86 out of 100 for Dr. Tevrizian for performance year 2024, reported as part of a group. Dr. Tevrizian accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Tevrizian as offering telehealth.

Dmand AI links 3 papers to Dr. Tevrizian, published from 2020 to 2021. Dr. Tevrizian's most frequent co-authors are Karna Gendo, MD, Katherine Cleveland Gilbert, MD and Matthew John Lodewick, MD.

CMS Open Payments shows 758 general payments to Dr. Tevrizian from 43 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 64% of the total. Sanofi and Genzyme US Companies paid the most, $25,236.

Dmand AI lists 1 award for Dr. Tevrizian, most recently CMS Stage 1 EHR in 2013.

Dr. Tevrizian graduated from Duke University School Of Medicine in 1996. Dr. Tevrizian is a member of AAAAI.

Dr. Tevrizian is in network with 14 carriers, including Aetna, Blue Cross Blue Shield of Michigan and United Healthcare. PPO plans come from the most carriers, 9. Check the plan with the practice before a visit.